| Bioactivity | Proxibarbal is a barbiturate derivative. It has anti-anxiety properties and is also used in the treatment of migraine headaches. |
| In Vivo | Proxibarbaland Valofan are tautomeric drugs which interconvert rapidly in solution. In the present study, the urinary excretion of these two drugs is investigated in two subjects after separate oral administration. In both cases, only Proxibarbalis found in urine, while the excretion of Valofan is negligible or non-detectable. More than half of a dose remains unaccounted for after Proxibarbal administration, and more than three quarters after Valofan administration[1]. |
| Name | Proxibarbal |
| CAS | 2537-29-3 |
| Formula | C10H14N2O4 |
| Molar Mass | 226.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wittekind HH, et al. Isomerisation and urinary excretion of proxibarbal and valofan in man; a preliminary study. Eur J Drug Metab Pharmacokinet. 1984 Apr-Jun;9(2):117-22. |
Proxibarbal
CAS: 2537-29-3 F: C10H14N2O4 W: 226.23
Proxibarbal is a barbiturate derivative. It has anti-anxiety properties and is also used in the treatment of migraine he
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.